STAR

Strides Pharma Science Share Price

 

 

Start SIP in STAR

Start SIP
Strides Pharma Science live price: ₹897.6. It opened at ₹895 vs previous close ₹907; intraday high/low: ₹916/₹891. The 50 & 200 DMA stand at ₹878.24/₹870.17.

Strides Pharma Science Performance

  • Today's Low
  • ₹891
  • Today's High
  • ₹916
  • 52 Week Low
  • ₹513
  • 52 Week High
  • ₹1,025
  • Open Price₹895
  • Previous Close₹907
  • Volume253,848
  • 50 DMA₹878.24
  • 100 DMA₹877.17
  • 200 DMA₹870.17

Investment Returns

  • Over 1 Month + 2.34%
  • Over 3 Month + 0.98%
  • Over 6 Month + 2.5%
  • Over 1 Year + 41.69%

Smart Investing Starts Here Start SIP with Strides Pharma Science for Steady Growth!

Invest Now

Strides Pharma Science Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 16.2
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 8,273
  • P/B Ratio
  • 2.8
  • Average True Range
  • 32.22
  • EPS
  • 59.78
  • Dividend Yield
  • 0.4
  • MACD Signal
  • 4.13
  • RSI
  • 55.09
  • MFI
  • 52.81

Strides Pharma Science Financials

Strides Pharma Science Technicals

EMA & SMA

Current Price
₹897.60
-9.45 (-1.04%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹880.87
  • 50 Day
  • ₹878.24
  • 100 Day
  • ₹877.17
  • 200 Day
  • ₹870.17

Resistance and Support

901.45 Pivot Speed
  • R3 938.15
  • R2 927.20
  • R1 912.40
  • S1 886.65
  • S2 875.70
  • S3 860.90

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Ltd. is a global pharmaceutical company engaged in the development, manufacturing, and marketing of generic drugs. It focuses on niche therapeutic segments, including anti-retrovirals, oncology, and central nervous system, serving markets worldwide.

Strides Pharma Science has an operating revenue of Rs. 4,725.61 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 11% is healthy, ROE of 140% is exceptional. The company has a reasonable debt to equity of 22%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 3% and 3% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 83 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Strides Pharma Science Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-30 Quarterly Results
2025-10-31 Quarterly Results
2025-07-29 Quarterly Results
2025-05-22 Audited Results & Final Dividend
2025-01-30 Quarterly Results
Date Purpose Remarks
2025-07-22 FINAL Rs.4.00 per share(40%)Final Dividend
2024-09-09 FINAL Rs.2.50 per share(25%)Final Dividend
2023-08-04 FINAL Rs.1.50 per share(15%)Final Dividend
2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend
View Strides Pharma Science Dividend History Arrow

Strides Pharma Science F&O

Strides Pharma Science Shareholding Pattern

27.86%
8.59%
3.05%
29.52%
0.01%
21.41%
9.56%

Strides Pharma Science FAQs

Strides Pharma Science share price is ₹897 As on 20 March, 2026 | 02:25

The Market Cap of Strides Pharma Science is ₹8273.4 Cr As on 20 March, 2026 | 02:25

The P/E ratio of Strides Pharma Science is 16.2 As on 20 March, 2026 | 02:25

The PB ratio of Strides Pharma Science is 2.8 As on 20 March, 2026 | 02:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23